Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.59 |
| ▸ | CA2 | P00918 | 5/20 | 0.59 |
| ▸ | CA9 | Q16790 | 5/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.59 |
| ▸ | CA12 | O43570 | 4/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | TOP1 | P11387 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | SNCA | P37840 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 4/20 | 0.49 |
| ▸ | TERT | O14746 | 1/20 | 0.49 |
| ▸ | XDH | P47989 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.47 |
| ▸ | NAMPT | P43490 | 1/20 | 0.47 |
| ▸ | JAK3 | P52333 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28703792 | 0.85 | CA12 (0.59) | CA1CA2CA9CA14CA12 | |
| SCHEMBL11089255 | 0.83 | HDAC6 (0.55) | CA1CA2CA9CA14CA12 | |
| SCHEMBL35401735 | 0.82 | KDM4E (0.55) | CA1CA2CA9CA14CA12 | |
| SCHEMBL18083916 | 0.80 | HDAC6 (0.60) | CA1CA2CA9CA14CA12 | |
| SCHEMBL18364959 | 0.80 | CA12 (0.65) | CA1CA2CA9CA14CA12 | |
| SCHEMBL17689597 | 0.79 | NR1H4 (0.56) | CA1CA2CA9CA14CA12 | |
| SCHEMBL24379050 | 0.78 | CA12 (0.58) | CA1CA2CA9CA14CA12 | |
| SCHEMBL31366876 | 0.78 | CA12 (0.54) | CA1CA2CA9CA14CA12 | |
| SCHEMBL22231515 | 0.78 | CA12 (0.54) | CA1CA2CA9CA14CA12 | |
| SCHEMBL10029414 | 0.77 | L3MBTL1 (0.58) | CA1CA2CA9CA14CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11286231-B2 | Hydrogen-bonding compounds, compositions comprising the same, and methods of preparing and using the same | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2022-03-29 | — | — | US | disclosed |
| US-20190345096-A1 | HYDROGEN-BONDING COMPOUNDS, COMPOSITIONS COMPRISING THE SAME, AND METHODS OF PREPARING AND USING THE SAME | WAKE FOREST UNIVERSITY | 2019-11-14 | — | — | US | disclosed |
| WO-2018081425-A1 | HYDROGEN-BONDING COMPOUNDS, COMPOSITIONS COMPRISING THE SAME, AND METHODS OF PREPARING AND USING THE SAME | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2018-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11286231-B2 | Hydrogen-bonding compounds, compositions comprising the same, and methods of preparing and using the same | F12, F5, F13B | CA1 411/4885CA2 1334/4885CA9 245/4885 |
| US-20190345096-A1 | HYDROGEN-BONDING COMPOUNDS, COMPOSITIONS COMPRISING THE SAME, AND METHODS OF PREPARING AND USING THE SAME | F12, F5, F13B | CA1 443/4885CA2 1267/4885CA9 235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.